Professor, Internal Medicine, University of Michigan Medical School
Cardiology
Dr. Eric R. Bates, MD
|
|
Give Review
Eric Bates is an expert in the field of Cardiology. He attended University of Michigan Medical School. He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Eric Bates is also published. He has 90 publications published. The lastest publication: "Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outco...'
Publications
- Optimal medical therapy with or without percutaneous Coronary intervention in women with stable Coronary disease: A pre-specified subset analysis of the Clinical Outco...
- Limiting Infarct Size in ST-Segment Myocardial Infarction: The Holy Grail of Reperfusion Therapy.
- Comparative effectiveness and safety of a catheterization laboratory-only eptifibatide dosing strategy in patients undergoing percutaneous Coronary intervention.
- Fibrinolysis Use Among Patients Requiring Interhospital Transfer for ST-Segment Elevation Myocardial Infarction Care: A Report From the US National Cardiovascular Data...
- The Evolution from Fibrinolytic Therapy to a Fibrinolytic Strategy for Patients with ST-Segment Elevation Myocardial Infarction.
- Predicting Outcome in the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): Coronary Anatomy Versus Ischemia.
- Concomitant Administration of Clopidogrel With Statins or Calcium Channel Blockers: Insights From the TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcom...
- Change in enrollment patterns, patient selection, and clinical outcomes with the availability of drug-eluting stents in the Bypass Angioplasty Revascularization Invest...
- Time to treatment in patients with STEMI.
- Emergency Department Bypass for ST-Segment-Elevation Myocardial Infarction Patients Identified With a Prehospital Electrocardiogram: A Report From the American Heart A...
- Mission: Lifeline STEMI Networks Geospatial Information Systems (GIS) Maps.
- Effect of percutaneous Coronary intervention on quality of life: A consensus statement from the society for cardiovascular angiography and interventions.
- Acute ST-elevation myocardial infarction.
- Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic Heart disease randomized to optimal medical therapy with or without ...
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on ...
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Associa...
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Associ...
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on...
- Operator experience and Carotid stenting outcomes in Medicare beneficiaries.
- Interventional cardiology: Antithrombotic drug and stent choices in Primary PCI.
- Treatment options in severe Aortic stenosis.
- ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensu...
- My stent is better than your stent...Or is it?
- Clopidogrel-drug interactions.
- ACP Journal Club. Adding colchicine to standard therapy after cardiac surgery reduced risk for the postpericardiotomy Syndrome.
- Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic Therapy.
- The role of the electrocardiogram as a prognostic tool in ST-segment elevation Myocardial infarction.
- Timeliness of treatment is more important than choice of reperfusion therapy.
- Genetic causes of clopidogrel nonresponsiveness: which ones really count?
- Temporal trends in the use of drug-eluting stents for approved and off-label indications: a longitudinal analysis of a large multicenter percutaneous Coronary interven...
- Percutaneous Coronary intervention or Coronary artery bypass surgery for cardiogenic shock and multivessel Coronary artery disease?
- ACP Journal Club. Ticagrelor was more effective than clopidogrel, with no increase in major bleeding in Acute coronary syndromes.
- 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation Myocardial infarction (updating the 2004 guideline and 2007 focused update) a...
- Clinical problem-solving. A change of Heart.
- A comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous Coronary intervention: a meta-analysis of con...
- ACP Journal Club. Review: Sgarbossa scores > or = 3 have low sensitivity and high specificity for predicting MI in left bundle branch block.
- Primary percutaneous Coronary intervention with drug-eluting stents: another chapter in the stent controversy.
- Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies.
- Review: limited evidence suggests that statins are safe in patients with liver Disease.
- Clinical profile of prasugrel, a novel thienopyridine.
- Platelet inhibitor therapy: current perspectives and emerging novel agents: introduction.
- Commentary: the role of percutaneous Coronary intervention in ST-segment-elevation myocardial infarction.
- Aspirating and filtering atherothrombotic debris during percutaneous Coronary intervention.
- Primary percutaneous Coronary intervention expansion to hospitals without on-site cardiac surgery in Michigan: a geographic information systems analysis.
- Challenging Coronary artery revascularization paradigms.
- Enoxaparin was more effective than unfractionated heparin in STEMI, regardless of type of fibrinolytic agent used.
- Cardiogenic shock complicating Myocardial infarction.
- The Editor's Roundtable: arterial thrombosis and Acute coronary syndromes.
- New anticoagulant options for ST-elevation myocardial infarction and unstable Angina pectoris/non-ST-elevation myocardial infarction.
- Role of intravenous beta-blockers in the treatment of ST-elevation Myocardial infarction: of mice (dogs, pigs) and men.
- Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus.
- Drug-eluting stents increased risk for late cardiac death or Myocardial infarction more than bare-metal stents.
- Review: drug-eluting stents for Coronary artery disease do not reduce mortality more than bare-metal stents.
- ACCF/AHA/CDC conference report on emerging infectious Diseases and biological terrorism threats: the clinical and public health implications for the prevention and con...
- Hospital delays in reperfusion for ST-elevation Myocardial infarction: implications when selecting a reperfusion strategy.
- Early revascularization improved long-term survival after Myocardial infarction with cardiogenic shock.
- Broken bodies, broken Hearts? Limitations of the trauma system as a model for regionalizing care for ST-elevation myocardial infarction in the United States.
- Interhospital transfer for early revascularization in patients with ST-elevation Myocardial infarction complicated by cardiogenic shock--a report from the SHould we re...
- Usefulness of translesional pressure gradient and pharmacological provocation for the assessment of intermediate renal artery Disease.
- Letter by Tsai et al regarding article, "correlates and long-term outcomes of angiographically proven stent Thrombosis with sirolimus- and Paclitaxel-eluting sten...
- Review: low-molecular-weight heparin is more effective than unfractionated heparin for preventing reInfarction in STEMI.
- Driving times and distances to hospitals with percutaneous Coronary intervention in the United States: implications for prehospital triage of patients with ST-elevatio...
- Circumferential pulmonary-vein ablation for chronic Atrial fibrillation.
- Management of cardiogenic shock attributable to Acute myocardial infarction in the reperfusion era.
- Loading, pretreatment, and interindividual variability issues with clopidogrel dosing.
- Controversies in antiplatelet therapy for patients with cardiovascular Disease.
- An early invasive strategy reduced death or MI better than a conservative strategy in unstable Angina and non-STEMI at advanced age.
- Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis.
- Current role of antithrombotic agents in the treatment of Acute coronary syndromes.
- Primary percutaneous coronary intervention versus fibrinolytic therapy in Acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance o...
- Clinical significance of the atorvastatin-clopidogrel drug-drug interaction.
- ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Ta...
- Angioplasty at an invasive-treatment center reduced mortality compared with first-contact thrombolysis.
- Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance.
- Periprocedural Myocardial infarction and mortality: causality versus association.
- Percutaneous coronary intervention versus fibrinolytic therapy in Acute myocardial infarction: is timing (almost) everything?
- Both invasive and optimized medical therapies improved quality of life in Angina but invasive therapy had fewer major adverse cardiac events.
- Review: PTCA reduces adverse cardiac outcomes and death better than thrombolytics after Myocardial infarction.
- Prognostic implication of troponin I elevation after percutaneous Coronary intervention.
- Reducing costs and improving outcomes of percutaneous Coronary interventions.
- Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction.
- Direct thrombin inhibitors in cardiac Disease.
- Patient outcomes after fibrinolytic therapy for Acute myocardial infarction at hospitals with and without coronary revascularization capability.
- Review: glycoprotein IIb/IIIa inhibitors reduced death or MI in Acute coronary syndromes not routinely scheduled for revascularization.
- Competitive bidding for interventional cardiology supplies: lessons learned during round 2.
- Review: platelet glycoprotein IIb/IIIa blockers for PCI or Acute coronary syndromes reduce death and MI but increase bleeding.
- A randomized controlled trial of information-giving to patients referred for Coronary angiography: effects on outcomes of care.
- Primary Angioplasty Is the Optimal Approach to Early Reperfusion in Patients with Acute Myocardial Infarction.
- Reperfusion Therapy Reduces the Risk of Myocardial Rupture Complicating ST-Elevation Myocardial Infarction.
Schools
University Of Michigan Medical School
University Mich Med Center
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
University of Michigan Hospitals and Health Centers -
University of Michigan Medical School
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1619055266 | |
| NPPES Provider LastName | BATES | |
| NPPES Provider FirstName | ERIC | |
| NPPES Provider ZIPCode | 481059484 | |
| NPPES Provider State | MI | |
| Specialty Description | Cardiology | |
| Total Claim Count | 456.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1619055266 |
| Last Name Of The Provider | BATES |
| First Name Of The Provider | ERIC |
| View All |
Similar Doctors
|
|
Dr. Palak Shah, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Geoffrey D. Barnes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melvyn Rubenfire, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melinda B. Davis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Reema Hasan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Theodore J. Kolias, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan D. Goldberg, MD |
|
|
Dr. Alla Lubovich, MD |
|
|
Dr. Jason M. Wu, MD |
|
|
Dr. Wouter V. Saint-Phard, MD |
|
|
Dr. Michael P. Thomas, MD |